Skip to main content

Table 3 Haplotype distribution of TGF-β1 polymorphisms in NPC cases and controls

From: No association between TGF-β1 polymorphisms and risk of nasopharyngeal carcinoma in a large North African case-control study

Haplotype TGF-β1 −509–TGF-β1 869

Cases 2n = 600 (%)

Controls 2n = 598 (%)

OR (CI 95 %)a

P-value

C– T

295 (49.17)

304 (50.84)

1.00

-

T– C

190 (31.67)

183 (30.60)

1.07 (0.82–1.38)

0.608

C– C

69 (11.50)

60 (10.03)

1.18 (0.80–1.73)

0.382

T– T

46 (7.66)

51 (8.53)

0.92 (0.60–1.43)

0.738

  1. n number of subjects
  2. aUnadjusted Odds ratios and confidence interval for case-control comparison